Clinitech Laboratory Ltd vs Dr Lal Pathlabs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 23, 2026

Key Highlights

The Latest Trading Price of Clinitech Laboratory Ltd is ₹ 32 as of 07 Oct 15:30 . The P/E Ratio of Clinitech Laboratory Ltd changed from 23.3 on March 2025 to 19.1 on March 2026 . This represents a CAGR of -9.46% over 2 yearsThe P/E Ratio of Dr Lal Pathlabs Ltd changed from 77.4 on March 2021 to 43.6 on March 2026 . This represents a CAGR of -9.12% over 6 years The Market Cap of Clinitech Laboratory Ltd changed from ₹ 9.18 crore on March 2025 to ₹ 7.99 crore on March 2026 . This represents a CAGR of -6.71% over 2 yearsThe Market Cap of Dr Lal Pathlabs Ltd changed from ₹ 22565 crore on March 2021 to ₹ 22015 crore on March 2026 . This represents a CAGR of -0.41% over 6 years The revenue of Clinitech Laboratory Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Dr Lal Pathlabs Ltd for the Jun '26 is ₹ 829.6 crore as compare to the Mar '26 revenue of ₹ 726.7 crore. This represent the growth of 14.16% The ebitda of Clinitech Laboratory Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Dr Lal Pathlabs Ltd for the Jun '26 is ₹ 279.4 crore as compare to the Mar '26 ebitda of ₹ 210.8 crore. This represent the growth of 32.54% The net profit of Clinitech Laboratory Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Dr Lal Pathlabs Ltd changed from ₹ 107.8 crore to ₹ 170.5 crore over 9 quarters. This represents a CAGR of 22.60% The Dividend Payout of Clinitech Laboratory Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Dr Lal Pathlabs Ltd changed from 59.51 % on March 2021 to 67.59 % on March 2026 . This represents a CAGR of 2.14% over 6 years .

About Clinitech Laboratory Ltd

Clinitech Laboratory Limited was incorporated as Clinitech Laboratory Private Limited on March 19, 2010 with the Registrar of Companies, Mumbai.
The status of Company was changed to Public Limited and the name of Company changed to Clinitech Laboratory Limited through fresh certificate of incorporation upon conversion on August 25, 2023 was issued by the Registrar of Companies, Mumbai.
Company is in the business of healthcare services providing superior quality services such as pathology testing laboratories, diagnostic centers, scan centers, X-ray and ECG clinics, etc. The Company established a new Lab in Kalyan in 2012, NABL Accreditation at Airoli Centre in 2016, a new Lab at Thane in 2018.
Besides these, the Company conduct more than 150 tests including Biochemistry, Immunology, Hematology, Molecular Biology tests, urine analysis, Serology, Microbiology and Histopathology tests.

About Dr Lal Pathlabs Ltd

Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name Dr. Lal PathLabs Private Limited', on February 14, 1995 at Delhi.
The business of the Partnership Firm, Central Clinical Laboratory was undertaken by the Company.
The Company converted into a Public Limited Company and name of the Company was changed to Dr. Lal PathLabs Limited' vide fresh Certificate of Incorporation granted by the RoC on August 19, 2015. Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres.
Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

FAQs for the comparison of Clinitech Laboratory Ltd and Dr Lal Pathlabs Ltd

Which company has a larger market capitalization, Clinitech Laboratory Ltd or Dr Lal Pathlabs Ltd?

Market cap of Clinitech Laboratory Ltd is 7 Cr while Market cap of Dr Lal Pathlabs Ltd is 30,977 Cr

What are the key factors driving the stock performance of Clinitech Laboratory Ltd and Dr Lal Pathlabs Ltd?

The stock performance of Clinitech Laboratory Ltd and Dr Lal Pathlabs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Clinitech Laboratory Ltd and Dr Lal Pathlabs Ltd?

As of October 23, 2026, the Clinitech Laboratory Ltd stock price is INR ₹32.0. On the other hand, Dr Lal Pathlabs Ltd stock price is INR ₹1845.55.

How do dividend payouts of Clinitech Laboratory Ltd and Dr Lal Pathlabs Ltd compare?

To compare the dividend payouts of Clinitech Laboratory Ltd and Dr Lal Pathlabs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.